Literature DB >> 31253537

Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management.

Yuzo Suzuki1, Takafumi Suda2.   

Abstract

Eosinophilic pneumonia (EP) is a rare disorder, comprising several heterogeneous diseases. Two major types of EP are acute eosinophilic pneumonia (AEP) and chronic eosinophilic pneumonia (CEP), both of which are characterized by marked accumulation of eosinophils in lung tissues and/or BAL fluid. AEP and CEP share some similarities in terms of pathophysiology, radiological findings, and treatment response to corticosteroids. However, they distinctly differ in etiology, clinical manifestations, and the nature of disease course. Especially, although AEP and CEP respond well to corticosteroids, relapse frequently occurs in patients with CEP, but rarely in those with AEP. Although CEP occasionally persists and becomes corticosteroid dependent, most patients with AEP completely recover. This article reviews previous studies and discusses the etiology, clinical manifestations, and treatment of AEP and CEP.
Copyright © 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute eosinophilic pneumonia; Chronic eosinophilic pneumonia; Pulmonary function tests; Relapse; Smoking habit

Mesh:

Year:  2019        PMID: 31253537     DOI: 10.1016/j.alit.2019.05.006

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  19 in total

1.  Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.

Authors:  Emeline Brenard; Charles Pilette; Caroline Dahlqvist; Benoît Colinet; Florence Schleich; Florence Roufosse; Antoine Froidure
Journal:  Lung       Date:  2020-02-12       Impact factor: 2.584

2.  Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.

Authors:  Jiao-Jiao Chen; Xue-Chen Huo; Shao-Xia Wang; Fei Wang; Quan Zhao
Journal:  Int J Clin Pharm       Date:  2022-09-30

3.  Acute Eosinophilic Pneumonia Complicated with Venous Thromboembolic Disease-Diagnostic and Therapeutic Considerations.

Authors:  Ewa Jankowska; Iwona Bartoszuk; Katarzyna Lewandowska; Małgorzata Dybowska; Lucyna Opoka; Witold Tomkowski; Monika Szturmowicz
Journal:  Diagnostics (Basel)       Date:  2022-06-09

4.  Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report.

Authors:  Shimon Izhakian; Barak Pertzov; Dror Rosengarten; Mordechai R Kramer
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 5.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

Review 7.  Possible Mechanisms of Eosinophil Accumulation in Eosinophilic Pneumonia.

Authors:  Kazuyuki Nakagome; Makoto Nagata
Journal:  Biomolecules       Date:  2020-04-21

8.  Acute Eosinophilic Pneumonia Induced by Switching from Conventional Cigarette Smoking to Heated Tobacco Product Smoking.

Authors:  Tomoko Tajiri; Chisako Wada; Hirotsugu Ohkubo; Norihisa Takeda; Kensuke Fukumitsu; Satoshi Fukuda; Yoshihiro Kanemitsu; Takehiro Uemura; Masaya Takemura; Ken Maeno; Yutaka Ito; Tetsuya Oguri; Akio Niimi
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

Review 9.  Approach to Eosinophilia Presenting With Pulmonary Symptoms.

Authors:  Chen E Rosenberg; Paneez Khoury
Journal:  Chest       Date:  2020-09-28       Impact factor: 9.410

Review 10.  Vaping-Associated Respiratory Distress Syndrome: Case Classification and Clinical Guidance.

Authors:  Craig M Lilly; Shahzad Khan; Kathryn Waksmundzki-Silva; Richard S Irwin
Journal:  Crit Care Explor       Date:  2020-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.